The role of somatostatin and its analogs in the diagnosis and treatment of tumors
Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrinol Rev 1991;12:450-482.
Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: Evidence for different tumor subclasses
Reubi JC, Heitz PU, Landolt AM. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J Clin Endocrinol Metab 1987;65:65-73.
Clinically nonfunctioning pituitary adenoma and octreotide response to long-term high-dose treatment, and studies in vitro
de Bruin TWA, Kwekkeboom DJ, van't Verlaat JW, et al. Clinically nonfunctioning pituitary adenoma and octreotide response to long-term high-dose treatment, and studies in vitro. J Clin Endocrinol Metab 1992;75:1310-1317.
Somatostatin receptor scintigraphy with indium-111-DTPA-D-phe-1-octreotide in man: Metabolism, dosimetry and comparison with iodine-123-tyr-3-octreotide
Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-tyr-3-octreotide. J Nucl Med 1992;33:652-658.
The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker exametazime and single photon emission computed tomography (SPECT): Reproducibility and rater reliability
Ebmeier KP, Dougall NJ, Austin MPV, et al. The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker exametazime and single photon emission computed tomography (SPECT): reproducibility and rater reliability. Int J Meth Psych Res 1991;1:27-38.